Like what we observed in the GSR KO model, we found that TXNRD1/GSR DKO significantly reduced tumor number (tumor initiation) in both the KrasG12D/+, Nrf2+/+ mice and KrasG12D/+, Nrf2D29H/+ models (Fig. 4D). This evidence concerns the gene TXNRD1 and neoplasm.